VAXCYTE INC has a total of 13 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Singapore and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are LEE CHEN-YU, YE SONGSHENG and MOGON PHARMACEUTICALS SAGL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Singapore | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Philippines | 1 | |
#8 | Taiwan | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Fairman Jeffery | 10 |
#2 | Heinrichs Jon | 4 |
#3 | Chan Wei | 4 |
#4 | Kapoor Neeraj | 2 |
#5 | Jeffery Fairman | 1 |
#6 | Jon Heinrichs | 1 |
#7 | Fairman Jeffrey | 1 |
#8 | Wei Chan | 1 |
Publication | Filing date | Title |
---|---|---|
TW202102527A | Optimized cell-free synthesis of invasion plasmid antigen b and related compositions and methods of use | |
SG11202012905PA | Improvements in immunogenic conjugates |